| Bioactivity | Sigma-LIGAND-1 is a selective sigma receptor ligand with an IC50s of 16 nM, 19 nM at the DTG site and the PPP site, respectively. Sigma-LIGAND-1 has a Ki of 4000 nM at the dopamine D2 receptor[1]. | ||||||||||||
| Target | IC50: 16 nM (DTG site of sigma receptor), 19 nM (PPP site of sigma receptor)Ki: 4000 nM (Dopamine D2 receptor) | ||||||||||||
| In Vivo | Administration of Sigma-LIGAND-1 would reverse amphetamine-induced hyperlocomotion in mice, a behavioral model sensitive to antipsychotic compounds. Sigma-LIGAND-1 and its structural analogues have the potential antipsychotic activity[1]. | ||||||||||||
| Name | Sigma-LIGAND-1 | ||||||||||||
| CAS | 139652-01-0 | ||||||||||||
| Formula | C27H33NO4 | ||||||||||||
| Molar Mass | 435.56 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Erickson RH, et al. (Aminoalkoxy)chromones. Selective sigma receptor ligands. J Med Chem. 1992 May 1;35(9):1526-35. |